A new blood test could improve survival rates for pancreatic cancer – a disease which often tends to be diagnosed at later stages when treatment is less likely to be effective.
Pancreatic cancer is the fifth most common cause of cancer deaths in the UK, according to the NHS, with 10,500 people being diagnosed each year and only 7 per cent living five years or more after diagnosis.
